Cargando…

Characterization of peptide aptamers to the Anterior Gradient 2: a novel inhibitor of the tumour suppressor protein p53

Detalles Bibliográficos
Autores principales:	Fourtouna, A, Murray, E, Hayward, L, Pohler, L, Hupp, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300257/ http://dx.doi.org/10.1186/bcr1565

Ejemplares similares

Cellular localization of the proto-oncogenic p53 inhibitor AGR2 protein in breast cancer
por: Fourtouna, A, et al.
Publicado: (2008)

D133p53 isoform is a direct p53 target gene that modulates p53 tumour suppressor activity
por: Aoubala, M
Publicado: (2008)

Characterisation of the tumour suppressor gene ZAC in breast tissue
por: Valleley, EM, et al.
Publicado: (2006)

Inactivation of the retinoblastoma tumour suppressor pathway in premenopausal breast cancer is associated with resistance to tamoxifen
por: Lehn, S, et al.
Publicado: (2009)

NRG1 is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene
por: Chua, Y-L, et al.
Publicado: (2008)

D133P53, directly transactivated by p53, prevents p53-mediated apoptosis without inhibiting p53-mediated cell cycle arrest
por: Aoubala, M, et al.
Publicado: (2010)

Immune profiling of breast cancer patients: relationship between tumour antigen T cell responses with suppressor and effector leukocyte populations
por: Janssen, Nicole, et al.
Publicado: (2015)

Abnormal expression of p53 isoforms can be associated with poor survival in primary breast tumours
por: Bourdon, J-C
Publicado: (2008)

Anti-oestrogen therapy switches off tumour suppressors and proapoptotic genes in breast cancer and reveals a new therapeutic opportunity
por: Stone, A, et al.
Publicado: (2008)

MFSD2A is a novel lung tumour suppressor gene whose expression is modulated by a 5’-region polymorphism
por: Colombo, Francesca, et al.
Publicado: (2010)

P53. Effect of lymphodepletion and tumour on host and reconstituted regulatory T-cells in a model of murine melanoma
por: Kovács, J, et al.
Publicado: (2014)

Understanding p53 tumour suppressor network
por: Panatta, Emanuele, et al.
Publicado: (2021)

Lack of mutation in tumour-suppressor gene p53 in gestational trophoblastic tumours.
por: Shi, Y. F., et al.
Publicado: (1996)

HIV-1 subtype C primary isolates exhibit high sensitivity to an anti-gp120 RNA aptamer
por: Mufhandu, HT, et al.
Publicado: (2012)

Development of anti-MUC1 DNA aptamers for the imaging and radiotherapy of breast cancer
por: Da Pieve, C, et al.
Publicado: (2006)

Development of anti-MUC1 DNA aptamers for the imaging and radiotherapy of breast cancer
por: Da Pieve, C, et al.
Publicado: (2008)

Regional lactate and oxygen saturation gradients: preliminary experimental data
por: Pereira, A, et al.
Publicado: (2010)

Veno-arterial carbon dioxide gradient at the early stage of septic shock
por: Mallat, J, et al.
Publicado: (2010)

0356. Effect of the neuroprotective p53-inhibitor pifithrin-µ in a rodent cardiac arrest model
por: Springe, D, et al.
Publicado: (2014)

Activation and activities of the p53 tumour suppressor protein
por: Bálint, É, et al.
Publicado: (2001)

Tumourigenesis associated with the p53 tumour suppressor gene.
por: Chang, F., et al.
Publicado: (1993)

Peptide lineup against Gram-negative bacterial infection – first-in-class peptide inhibitor of H. pylori HtrA
por: Perna, Anna M, et al.
Publicado: (2014)

0097. Myeloid-derived suppressor cells attenuate inflammation and improve the survival of microbial sepsis
por: Tong, L, et al.
Publicado: (2014)

"Arming" the chimeric oncolytic adenovirus enadenotucirev to deliver checkpoint inhibitors and other therapeutics directly to tumours
por: Champion, Brian R, et al.
Publicado: (2014)

Policy gradient rules for populations of spiking neurons
por: Friedrich, Johannes, et al.
Publicado: (2011)

Thermodynamic characterization of the peptide assembly inhibitor binding to HIV-1 capsid protein
por: Kozisek, Milan, et al.
Publicado: (2013)

Tumor suppressor proteins restricts LINE-1 retrotransposition
por: Kuroki, Misao, et al.
Publicado: (2013)

A novel and selective PDK1 inhibitor reduces breast cancer cell invasion and tumour growth
por: Raimondi, C, et al.
Publicado: (2010)

Inhibition of HIV-1 subtype C by 2’F-RNA aptamers isolated against enveloped pseudovirus
por: London, GG, et al.
Publicado: (2012)

Do right atrium to mixed venous oxygen saturation gradients mirror heart oxygen uptake?
por: Pereira, AJ, et al.
Publicado: (2009)

Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.
por: Barton, C. M., et al.
Publicado: (1991)

p53β isoform modulates differentially p53 transcriptional activity in response to stress
por: Fernandes, K, et al.
Publicado: (2008)

Stochastic gradient ascent learning with spike timing dependent plasticity
por: Vieira, Joana, et al.
Publicado: (2011)

Whole heart DTI using asymmetric bipolar diffusion gradients
por: Froeling, Martijn, et al.
Publicado: (2015)

Venoarterial carbon dioxide gradient utility as a criterion for blood transfusion at the intensive care unit
por: Navarro, JL, et al.
Publicado: (2015)

Glioma microenvironment-derived CCL2 recruits regulatory T cells and myeloid-derived suppressor cells
por: Chang, Alan L, et al.
Publicado: (2015)

Anterior approach internal jugular vein catheterization
por: Kianfar, A, et al.
Publicado: (2006)

Expression of wild-type and mutated TP53 in breast carcinomas
por: Baumbusch, LO, et al.
Publicado: (2005)

Discussion of some ‘knowns’ and some ‘unknowns’ about the tumour suppressor p53
por: Lieschke, Elizabeth, et al.
Publicado: (2018)

Independent mechanisms of T cell-suppression by subpopulations of myeloid-derived suppressor cells (MDSC) in tumor-bearing hosts
por: Raber, Patrick L, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_h6686ieqm12vhg8plj1ibgenau